Ambulatory Surgical Centers Market is expected to reach US$ 150.6 billion by 2033 | FMI

 The global Ambulatory Surgical Centers Market reached US$ 96.5 billion in 2023 and is expected to reach US$ 150.6 billion by 2033, recording a CAGR of 4.5% over the forecast period.

Ambulatory Surgical Centers Market


The proliferation of ambulatory surgical centers is surging on account of accelerating demand for inpatient as well as outpatient care services. The escalating costs of healthcare at general hospitals have boosted the preference for ASCs among the public to get high-quality healthcare services.

Get Complete Access @ https://www.futuremarketinsights.com/reports/ambulatory-surgical-centre-market-092017

The ASCs offer adequate treatments to cure illnesses, along with providing many facilities including reimbursement policies and insurance options. Thus, providing a cost-effective treatment to patients, lower than the expenses incurred at hospitals.

At ASCs, physicians are in a better position to control expenses and patient experience. By concentrating on one specialty and owning the equipment, it becomes easier for healthcare providers to schedule procedures and run an operating room efficiently. Therefore, more physicians are opening up ASCs to cater to the growing demand for surgical procedures. Going forward, the ambulatory surgical centers market is being governed by the research and development activities initiated by key players for the advancement of the market.

Key Takeaways from the Ambulatory Surgical Centers Market: 

  • The U.S. market is predicted to maintain its prominent position over the forecast period as well, and reach US$ 73.5 billion by 2033. The market is predicted to record a CAGR of 4.5% from 2023 to 2033.
  • In Asia Pacific, Japan is estimated to attain US$ 5.7 billion by 2033. The market valuation of Japan is significant than China, which attained US$ 5.3 billion in the same year.
  • However, the growth of the market in China is projected to be 5% CAGR, greater than the 2.4% CAGR estimated for the market in Japan.
  • Over the forecast period, the surgical services segment is projected to emerge as the leading service, recording a CAGR of 4.6%.The  
  • Increasing number of ASCs delivering high-quality outpatient surgical care is projected to contribute towards the progress of this segment.

News Featuring Market Developments by Key Players of Ambulatory Surgical Centers:

  • In January 2023, Hudson Medical Center, a US$50 million and 1, 60,000 square foot facility, opened its gates for patients. At the same premises, the first ASC in St. Croix County, named Valley Surgery Center, will also be present. The center will be able to operate about 10,000 surgeries every year, after its commencement.
  • In August 2022, HCA Healthcare, a major healthcare provider in the U.S., announced its acquisition of Stone Oak Surgery Center, in association with 11 physician partners. The latter is a San Antonio-based ASC, authorized by the Centers for Medicare & Medicaid Services (CMS), and offers multispecialty services. With this acquisition, HCA Healthcare will extend its footprint in San Antonio.
  • Earlier, in January 2022, the company had revealed its decision to develop five new hospitals, offering all the necessary services in Texas. With this initiative, the company aims to cater to the rising need for healthcare services in the state.

For more information: https://www.futuremarketinsights.com/reports/ambulatory-surgical-centre-market-092017

Key Companies Profiled:

  • AmSurg Corp
  • Tenet Healthcare
  • HCA Holdings, Inc.
  • Surgical Care Affiliates, Inc.
  • Surgery Partners
  • Ambulatory Surgical Centers of America
  • Pinnacle III
  • Proliance Surgeons
  • Regent Surgical Health
  • SurgCenter Development

Ambulatory Surgical Centers Market by Category

By Centers Type:

  • Single Specialty Centers
  • MultiSpecialty Centers

By Modality:

  • Hospital-Based Ambulatory Surgical Center
  • Freestanding Ambulatory Surgical Center

By Services:

  • Diagnostic Services
  • Surgical Services

By Specialty Area:

·          

    • Gastroenterology
    • Ophthalmology
    • Orthopedics
    • Pain/Neurology
    • Urology
    • Dermatology
    • Others

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more